Protein Expression Market Size & Growth Analysis to 2030

Key Findings:

• The market size was valued at ~ US$ 3.5 Bn in 2023 and registering a significant CAGR of over 9% by 2030
• By expression system, the mammalian cell sub category is accounted to hold the largest market share in 2023
• Geographically, North America dominated the market in 2023 and expected to grow at the same trend over the forecast period to 2030

The global protein expression market size was valued at around USD 3.5 billion in 2023 and anticipated to grow at a significant CAGR of over 9% over the forecast period from 2024 to 2030. The market is driven by several key factors contributing to its rapid growth and adoption. Foremost is the increasing demand for biologics and biosimilars in the pharmaceutical industry, driven by their effectiveness in treating various diseases, including cancer, diabetes, and autoimmune disorders. Advancements in genetic engineering and recombinant DNA technology have significantly enhanced protein expression techniques, making the production of complex proteins more efficient and cost-effective. Additionally, the expanding applications of protein expression in research and development, including drug discovery, structural biology, and functional genomics, further fuel market growth. Government and private sector investments in biotechnology research, along with a growing emphasis on personalized medicine, also play crucial roles. Furthermore, the rise in chronic diseases and the need for novel therapeutic proteins and vaccines are creating a robust demand for advanced protein expression systems.

Market Snapshot:

To know more about the research report, request report sample

Market Trends:

Advancements in Expression Systems: The field of protein expression is witnessing significant advancements in various expression systems, including mammalian, bacterial, yeast, and insect cell systems. These improvements are making protein production more efficient and scalable, allowing for the generation of complex proteins that are often difficult to produce using traditional methods. Enhanced expression systems offer higher yield, better post-translational modifications, and increased stability of proteins, meeting the growing demands in pharmaceutical manufacturing and biomedical research.

Rise of Biologics and Biosimilars: The increasing popularity of biologics—therapeutic proteins, antibodies, and vaccines derived from living organisms—is a major driver of the protein expression market. Biologics are highly effective in treating a wide range of diseases, including cancer, autoimmune disorders, and infectious diseases. As patents for many blockbuster biologic drugs expire, there is a surge in the development of biosimilars, which are lower-cost alternatives. This trend is creating substantial demand for advanced protein expression technologies to produce these complex biological molecules efficiently.

Automation and High-Throughput Technologies: The adoption of automation and high-throughput technologies in protein expression and purification is transforming the industry. Automated systems streamline the workflow, enabling rapid screening and optimization of expression conditions. High-throughput technologies allow for the simultaneous processing of multiple samples, increasing productivity and reducing time and costs associated with protein production. These advancements are particularly beneficial in drug discovery and development, where speed and efficiency are crucial.

Increased Funding and Investment: There is a notable increase in funding and investments from government bodies, private sectors, and venture capitalists in biotechnology and pharmaceutical research. This financial support is driving advancements in protein expression technologies and expanding their applications. Government grants and funding initiatives are promoting research and development activities, while private investments are accelerating the commercialization of innovative protein expression systems and therapeutic proteins.

Expansion of Personalized Medicine: The trend towards personalized medicine is significantly impacting the protein expression market. Personalized medicine involves tailoring treatments to individual patients based on their genetic makeup, disease profile, and other factors. This approach is driving the demand for customized protein therapeutics, which can be produced using advanced protein expression systems. These systems enable the production of tailored therapeutic proteins and peptides, offering more effective and targeted treatments for patients.

Market Opportunities:

The global protein expression market offers substantial opportunities driven by technological advancements and expanding applications. With the rise of biologics and biosimilars, there is a growing need for efficient and scalable protein production systems, presenting opportunities for companies to develop and commercialize innovative expression technologies. The increasing emphasis on personalized medicine further fuels demand for tailored protein therapeutics, creating a niche for customized expression systems. Additionally, emerging markets in Asia-Pacific and Latin America are witnessing rapid growth in biotechnology and pharmaceutical sectors, providing a fertile ground for market expansion. Investments in research and development, coupled with collaborations between academia, industry, and regulatory bodies, are fostering innovation and facilitating the development of next-generation protein expression solutions. Furthermore, the focus on sustainable and eco-friendly production processes aligns with global environmental goals, offering opportunities for companies to differentiate themselves by adopting green technologies.

Market Restraints:

Despite its growth potential, the global protein expression market faces several restraining factors. High production costs and complexities associated with protein expression and purification processes can limit accessibility, especially for smaller companies and research institutions. Additionally, the stringent regulatory landscape governing biopharmaceutical production imposes rigorous standards and approval processes, which can delay product development and market entry. Technical challenges, such as achieving high yield and quality of expressed proteins, particularly for complex or difficult-to-express proteins, also pose significant hurdles. Limited availability of skilled professionals proficient in advanced protein expression techniques further exacerbates these challenges. Moreover, intellectual property issues and patent expirations can hinder innovation and competition within the market.

Market Insights:

The global protein expression market is bifurcated into expression system, product type, application, end-use, and geography. On the basis of expression system, the market is further segmented into prokaryotic, mammalian cell, insect cell, yeast, and others. The mammalian cell expression system dominated the market in the benchmark year 2023. This system is particularly favored in the biopharmaceutical industry due to its ability to produce complex proteins with proper post-translational modifications, such as glycosylation and phosphorylation, which are critical for the biological activity and efficacy of therapeutic proteins. Mammalian cells, such as Chinese Hamster Ovary (CHO) cells, are widely used to manufacture monoclonal antibodies, hormones, and other therapeutic proteins that require a human-like cellular environment for proper folding and functionality. The high demand for biologics, including therapeutic antibodies and vaccines, drives the preference for mammalian cell expression systems, making them the market leader in terms of revenue and application scope.

Despite higher production costs and longer culture times compared to other expression systems, mammalian cell expression systems are indispensable for producing biopharmaceuticals that meet stringent regulatory standards for safety and efficacy. The ongoing advancements in genetic engineering, bioprocessing technologies, and cell line development further enhance the efficiency and yield of mammalian cell-based production. As personalized medicine and precision therapies gain traction, the demand for customized therapeutic proteins is expected to grow, reinforcing the dominance of mammalian cell expression systems in the protein expression market. This segment’s ability to meet the complex requirements of modern biologics ensures its leading position and continued growth in the industry.

The Protein Expression market research report presents the analysis of each segment from 2020 to 2030 considering 2023 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2024 to 2030.

Historical & Forecast Period

• 2020-22 – Historical Year
• 2023 – Base Year
• 2024-2030 – Forecast Period

Market Segmentation:

By Expression System:

• Prokaryotic
• Mammalian Cell
• Insect Cell
• Yeast
• Others

By Product Type:

• Reagents
• Competent Cells
• Expression Vectors
• Services
• Instruments

By Application:

• Therapeutic
• Industrial
• Research

By End-Use:

• Pharmaceutical & Biotechnological Companies
• Academic Research
• Contract research organizations
• Others

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Regional Analysis:

Geographically, the dominant region in the global protein expression market is North America. This region, particularly the United States, has a well-established biotechnology and pharmaceutical industry, supported by significant investments in research and development. The presence of major biopharmaceutical companies, research institutions, and academic organizations drives innovation and technological advancements in protein expression. Additionally, the region benefits from robust funding from both private and public sectors, including substantial grants from government agencies such as the National Institutes of Health (NIH). This financial support accelerates the development of new protein expression technologies and their applications in drug discovery, development, and manufacturing.

Moreover, North America has a favorable regulatory environment that facilitates the approval and commercialization of biologics and biosimilars. The U.S. Food and Drug Administration (FDA) has established clear guidelines and pathways for the development and approval of protein-based therapeutics, ensuring high standards of safety and efficacy. This regulatory framework, combined with a strong focus on personalized medicine and increasing prevalence of chronic diseases, drives the demand for advanced protein expression systems in the region. Furthermore, the high adoption rate of cutting-edge technologies, well-developed infrastructure, and a skilled workforce contribute to North America’s leading position in the protein expression market. As the demand for biologics continues to rise, North America’s dominance is expected to persist, fostering continued growth and innovation in the industry.

Competitive Landscape:

Some of the prominent market players operating in the global Protein Expression market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies, Inc., Qiagen N.V., and Bio-Rad Laboratories, Inc. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

Key Companies:

• Thermo Fisher Scientific Inc.
• Merck KGaA
• Agilent Technologies, Inc.
• Qiagen N.V.
• Bio-Rad Laboratories, Inc.
• Lonza Group Ltd.
• New England Biolabs, Inc.
• GenScript Biotech Corporation
• Promega Corporation
• Takara Bio Inc.

Key Questions Answered by Protein Expression Market Report

• Global Protein Expression market forecasts from 2024-2030
• Regional market forecasts from 2024-2030 covering Asia-Pacific, North America, Europe, Middle East & Africa, and Latin America
• Country-level forecasts from 2024-2030 covering 15 major countries from the regions as mentioned above
• Protein Expression submarket forecasts from 2024-2030 covering the market by expression system, product type, application, end-use, and geography
• Various industry models such as SWOT analysis, Value Chain Analysis about the market
• Analysis of the key factors driving and restraining the growth of the global, regional, and country-level Protein Expression markets from 2024-2030
• Competitive Landscape and market positioning of top 10 players operating in the market